Firmenbeschreibung
Vertex Pharmaceuticals Inc. ist ein globales Biotech-Unternehmen, das sich der Entdeckung und Entwicklung kleinmolekularer Arzneimittel zur Behandlung von schweren Erkrankungen verschrieben hat. Die Strategie des Unternehmens besteht aus der Vermarktung seiner Produkte sowohl unabhängig als auch gemeinsam mit führenden Pharmakonzernen. Die Produktpipeline von Vertex ist hauptsächlich auf Virusinfektionen, Entzündungen, Autoimmunkrankheiten und Krebs ausgerichtet. Vertex vermarktet den HIV-Proteasehemmer Lexiva gemeinsam mit GlaxoSmithKline.
KeyData
endOfFinancialYear: | 31.12.2022 01:00 |
stockholderStructure: | Blackrock Inc. (8.84%),Vanguard Group Inc (8.48%),Capital World Investors (6.72%),FMR, LLC (5.67%),State Street Corporation (4.78%),Wellington Management Group, LLP (2.93%),Alliancebernstein L.P. (2.92%),Price (T.Rowe) Associates Inc (2.62%),JP Morgan Chase & Company (2.31%),Geode Capital Management, LLC (2.15%) |
sharesOutstanding: | 258307816.0000 |
ceo: | Reshma Kewalramani, M.D. |
board: | Charles F. Wagner, Jr., David Altshuler, Stuart A. Arbuckle, Jonathan Biller, Carmen Bozic, Amit K. Sachdev, Bastiano Sanna, Nia Tatsis, E. Morrey Atkinson, Ph.D. |
supervisoryBoard: | Dr. Jeffrey Leiden, Bruce I. Sachs, Diana McKenzie, Dr. Alan Garber, Dr. Sangeeta N. Bhatia, Lloyd Carney, Reshma Kewalramani, Terrence C. Kearney, Suketu (Suky) Upadhyay |
countryID: | 20 |
freeFloat: | 82.7000 |
faceValue: | 0.0100 |
faceValueCurrencyID: | 4 |
faceValueCurrency: | USD |
sectorName: | Pharmazeutische Industrie |
industryName: | Gesundheitswesen |
subsectorName: | Pharmazeutische Industrie |
country: | USA |
countryName: | USA |
Kontakt
name: | Susie Lisa |
phone: | +1-617-341-6108 |
email: | investorinfo@vrtx.com |
irWebSite: | https://investors.vrtx.com/ |
Adresse
street: | 50 Northern Avenue |
city: | Boston, Massachusetts 02210, USA |
phone: | +1-617-961-7163 |
webSite: | www.vrtx.com/ |
email: | Investorinfo@VRTX.com |
Finanzen (kurz)
year: | 2021 | cash: | 6795.0000 |
balanceSheetTotal: | 13432.5000 | liabilities: | 3332.5000 |
shareCapital: | 2.5000 | totalShareholdersEquity: | 10100.0000 |
sales: | 7574.4000 | investment: | 4.9000 |
incomeBeforeTaxes: | 2730.4000 | netIncome: | 2342.1000 |
cashFlow: | 811.2000 | employees: | 3900 |
currencyID: | 4 | units: | 1000000 |
currency: | USD |
year: | 2022 | cash: | 10504.0000 |
balanceSheetTotal: | 18150.9000 | liabilities: | 4238.2000 |
shareCapital: | 2.6000 | totalShareholdersEquity: | 13912.7000 |
sales: | 8930.7000 | incomeBeforeTaxes: | 4232.4000 |
netIncome: | 3322.0000 | cashFlow: | 3711.9000 |
currencyID: | 4 | units: | 1000000 |
currency: | USD |
year: | 2023 | cash: | 10369.1000 |
balanceSheetTotal: | 22730.2000 | liabilities: | 5149.8000 |
shareCapital: | 2.6000 | totalShareholdersEquity: | 17580.4000 |
sales: | 9869.2000 | incomeBeforeTaxes: | 4379.8000 |
netIncome: | 3619.6000 | cashFlow: | -139.7000 |
currencyID: | 4 | units: | 1000000 |
currency: | USD |
Finanzen (kurz)
year: | 2021 |
cash: | 6795.0000 |
balanceSheetTotal: | 13432.5000 |
liabilities: | 3332.5000 |
shareCapital: | 2.5000 |
totalShareholdersEquity: | 10100.0000 |
sales: | 7574.4000 |
investment: | 4.9000 |
incomeBeforeTaxes: | 2730.4000 |
netIncome: | 2342.1000 |
cashFlow: | 811.2000 |
employees: | 3900 |
currencyID: | 4 |
units: | 1000000 |
currency: | USD |
year: | 2022 |
cash: | 10504.0000 |
balanceSheetTotal: | 18150.9000 |
liabilities: | 4238.2000 |
shareCapital: | 2.6000 |
totalShareholdersEquity: | 13912.7000 |
sales: | 8930.7000 |
incomeBeforeTaxes: | 4232.4000 |
netIncome: | 3322.0000 |
cashFlow: | 3711.9000 |
currencyID: | 4 |
units: | 1000000 |
currency: | USD |
year: | 2023 |
cash: | 10369.1000 |
balanceSheetTotal: | 22730.2000 |
liabilities: | 5149.8000 |
shareCapital: | 2.6000 |
totalShareholdersEquity: | 17580.4000 |
sales: | 9869.2000 |
incomeBeforeTaxes: | 4379.8000 |
netIncome: | 3619.6000 |
cashFlow: | -139.7000 |
currencyID: | 4 |
units: | 1000000 |
currency: | USD |
Finanzen (ausführlich)
year: | 2022 | units: | 1000000 |
balanceSheetTotal: | 18150.9000 | cash: | 10504.0000 |
currentAssets: | 13234.8000 | fixedAssets: | 4916.1000 |
liabilities: | 2742.1000 | totalLiabilitiesEquity: | 18150.9000 |
totalShareholdersEquity: | 13912.7000 | property: | 1108.4000 |
intangibleAssets: | 603.6000 | inventories: | 460.6000 |
accountsReceivable: | 1442.2000 | accountsPayable: | 303.9000 |
liabilitiesTotal: | 4238.2000 | longTermDebt: | 430.8000 |
shortTermDebt: | 0.0000 | commonStock: | 2.6000 |
preferredStock: | 0.0000 | sales: | 8930.7000 |
depreciation: | 148.3000 | netIncome: | 3322.0000 |
operatingResult: | 4307.4000 | incomeInterest: | 54.8000 |
investments: | 2540.3000 | incomeTaxes: | 910.4000 |
costGoodsSold: | 1080.3000 | grossProfit: | 7850.4000 |
cashFlow: | 4129.9000 | cashFlowInvesting: | -321.1000 |
cashFlowFinancing: | -67.7000 | cashFlowTotal: | 3711.9000 |
accountingStandard: | US GAAP | equityRatio: | 76.6502 |
debtEquityRatio: | 30.4628 | liquidityI: | 383.0641 |
liquidityII: | 435.6588 | netMargin: | 37.1975 |
grossMargin: | 87.9035 | cashFlowMargin: | 46.2439 |
ebitMargin: | 48.2314 | ebitdaMargin: | 0.0000 |
preTaxROE: | 30.4211 | preTaxROA: | 23.3179 |
roe: | 23.8775 | roa: | 18.3021 |
netIncomeGrowth: | 41.8385 | revenuesGrowth: | 17.9064 |
taxExpenseRate: | 21.5103 | equityTurnover: | 0.6419 |
epsBasic: | 12.9700 | epsDiluted: | 12.8200 |
epsBasicGrowth: | 42.6843 | shareCapital: | 2.6000 |
incomeBeforeTaxes: | 4232.4000 | priceEarningsRatioCompany: | 22.2652 |
priceCashFlowRatio: | 17.9769 | bookValuePerShare: | 54.1158 |
marketCap: | 74242866331.9800 | earningsYield: | 4.4913 |
pegRatio: | 0.5216 | cashFlowPerShare: | 16.0639 |
priceBookValueRatio: | 5.3363 | priceEarningsRatio: | 22.3488 |
netEarningsPerShare: | 12.9215 | currency: | USD |
year: | 2023 | units: | 1000000 |
balanceSheetTotal: | 22730.2000 | cash: | 10369.1000 |
currentAssets: | 14144.2000 | fixedAssets: | 8586.0000 |
liabilities: | 3547.4000 | totalLiabilitiesEquity: | 22730.2000 |
totalShareholdersEquity: | 17580.4000 | property: | 1159.3000 |
intangibleAssets: | 839.9000 | inventories: | 738.8000 |
accountsReceivable: | 1563.4000 | accountsPayable: | 364.9000 |
liabilitiesTotal: | 5149.8000 | longTermDebt: | 376.1000 |
commonStock: | 2.6000 | preferredStock: | 0.0000 |
sales: | 9869.2000 | depreciation: | 181.3000 |
netIncome: | 3619.6000 | operatingResult: | 3832.0000 |
incomeInterest: | 44.1000 | investments: | 3162.9000 |
incomeTaxes: | 760.2000 | costGoodsSold: | 1262.2000 |
grossProfit: | 8607.0000 | cashFlow: | 3537.3000 |
cashFlowInvesting: | -3141.7000 | cashFlowFinancing: | -562.2000 |
cashFlowTotal: | -139.7000 | accountingStandard: | US GAAP |
equityRatio: | 77.3438 | debtEquityRatio: | 29.2928 |
liquidityI: | 292.3014 | liquidityII: | 336.3731 |
netMargin: | 36.6757 | grossMargin: | 87.2107 |
cashFlowMargin: | 35.8418 | ebitMargin: | 38.8279 |
ebitdaMargin: | 0.0000 | preTaxROE: | 24.9130 |
preTaxROA: | 19.2686 | roe: | 20.5888 |
roa: | 15.9242 | netIncomeGrowth: | 8.9585 |
revenuesGrowth: | 10.5087 | taxExpenseRate: | 17.3570 |
equityTurnover: | 0.5614 | epsBasic: | 14.0500 |
epsDiluted: | 13.8900 | epsBasicGrowth: | 8.3269 |
shareCapital: | 2.6000 | incomeBeforeTaxes: | 4379.8000 |
priceEarningsRatioCompany: | 28.9601 | priceCashFlowRatio: | 29.7127 |
bookValuePerShare: | 68.0599 | marketCap: | 105102867252.2400 |
earningsYield: | 3.4530 | pegRatio: | 3.4779 |
cashFlowPerShare: | 13.6941 | priceBookValueRatio: | 5.9784 |
priceEarningsRatio: | 29.0371 | netEarningsPerShare: | 14.0127 |
currency: | USD |
year: | 2024 | priceEarningsRatioCompany: | 28.0626 |
priceCashFlowRatio: | 28.7919 | bookValuePerShare: | 68.0599 |
marketCap: | 101845605692.4800 | earningsYield: | 3.5635 |
pegRatio: | 3.3701 | cashFlowPerShare: | 13.6941 |
netAssetsPerShare: | 68.0599 | priceBookValueRatio: | 5.7931 |
priceEarningsRatio: | 28.1373 | netEarningsPerShare: | 14.0127 |
currency: | USD |
Finanzen (ausführlich)
year: | 2022 |
units: | 1000000 |
balanceSheetTotal: | 18150.9000 |
cash: | 10504.0000 |
currentAssets: | 13234.8000 |
fixedAssets: | 4916.1000 |
liabilities: | 2742.1000 |
totalLiabilitiesEquity: | 18150.9000 |
totalShareholdersEquity: | 13912.7000 |
property: | 1108.4000 |
intangibleAssets: | 603.6000 |
inventories: | 460.6000 |
accountsReceivable: | 1442.2000 |
accountsPayable: | 303.9000 |
liabilitiesTotal: | 4238.2000 |
longTermDebt: | 430.8000 |
shortTermDebt: | 0.0000 |
commonStock: | 2.6000 |
preferredStock: | 0.0000 |
sales: | 8930.7000 |
depreciation: | 148.3000 |
netIncome: | 3322.0000 |
operatingResult: | 4307.4000 |
incomeInterest: | 54.8000 |
investments: | 2540.3000 |
incomeTaxes: | 910.4000 |
costGoodsSold: | 1080.3000 |
grossProfit: | 7850.4000 |
cashFlow: | 4129.9000 |
cashFlowInvesting: | -321.1000 |
cashFlowFinancing: | -67.7000 |
cashFlowTotal: | 3711.9000 |
accountingStandard: | US GAAP |
equityRatio: | 76.6502 |
debtEquityRatio: | 30.4628 |
liquidityI: | 383.0641 |
liquidityII: | 435.6588 |
netMargin: | 37.1975 |
grossMargin: | 87.9035 |
cashFlowMargin: | 46.2439 |
ebitMargin: | 48.2314 |
ebitdaMargin: | 0.0000 |
preTaxROE: | 30.4211 |
preTaxROA: | 23.3179 |
roe: | 23.8775 |
roa: | 18.3021 |
netIncomeGrowth: | 41.8385 |
revenuesGrowth: | 17.9064 |
taxExpenseRate: | 21.5103 |
equityTurnover: | 0.6419 |
epsBasic: | 12.9700 |
epsDiluted: | 12.8200 |
epsBasicGrowth: | 42.6843 |
shareCapital: | 2.6000 |
incomeBeforeTaxes: | 4232.4000 |
priceEarningsRatioCompany: | 22.2652 |
priceCashFlowRatio: | 17.9769 |
bookValuePerShare: | 54.1158 |
marketCap: | 74242866331.9800 |
earningsYield: | 4.4913 |
pegRatio: | 0.5216 |
cashFlowPerShare: | 16.0639 |
priceBookValueRatio: | 5.3363 |
priceEarningsRatio: | 22.3488 |
netEarningsPerShare: | 12.9215 |
currency: | USD |
year: | 2023 |
units: | 1000000 |
balanceSheetTotal: | 22730.2000 |
cash: | 10369.1000 |
currentAssets: | 14144.2000 |
fixedAssets: | 8586.0000 |
liabilities: | 3547.4000 |
totalLiabilitiesEquity: | 22730.2000 |
totalShareholdersEquity: | 17580.4000 |
property: | 1159.3000 |
intangibleAssets: | 839.9000 |
inventories: | 738.8000 |
accountsReceivable: | 1563.4000 |
accountsPayable: | 364.9000 |
liabilitiesTotal: | 5149.8000 |
longTermDebt: | 376.1000 |
commonStock: | 2.6000 |
preferredStock: | 0.0000 |
sales: | 9869.2000 |
depreciation: | 181.3000 |
netIncome: | 3619.6000 |
operatingResult: | 3832.0000 |
incomeInterest: | 44.1000 |
investments: | 3162.9000 |
incomeTaxes: | 760.2000 |
costGoodsSold: | 1262.2000 |
grossProfit: | 8607.0000 |
cashFlow: | 3537.3000 |
cashFlowInvesting: | -3141.7000 |
cashFlowFinancing: | -562.2000 |
cashFlowTotal: | -139.7000 |
accountingStandard: | US GAAP |
equityRatio: | 77.3438 |
debtEquityRatio: | 29.2928 |
liquidityI: | 292.3014 |
liquidityII: | 336.3731 |
netMargin: | 36.6757 |
grossMargin: | 87.2107 |
cashFlowMargin: | 35.8418 |
ebitMargin: | 38.8279 |
ebitdaMargin: | 0.0000 |
preTaxROE: | 24.9130 |
preTaxROA: | 19.2686 |
roe: | 20.5888 |
roa: | 15.9242 |
netIncomeGrowth: | 8.9585 |
revenuesGrowth: | 10.5087 |
taxExpenseRate: | 17.3570 |
equityTurnover: | 0.5614 |
epsBasic: | 14.0500 |
epsDiluted: | 13.8900 |
epsBasicGrowth: | 8.3269 |
shareCapital: | 2.6000 |
incomeBeforeTaxes: | 4379.8000 |
priceEarningsRatioCompany: | 28.9601 |
priceCashFlowRatio: | 29.7127 |
bookValuePerShare: | 68.0599 |
marketCap: | 105102867252.2400 |
earningsYield: | 3.4530 |
pegRatio: | 3.4779 |
cashFlowPerShare: | 13.6941 |
priceBookValueRatio: | 5.9784 |
priceEarningsRatio: | 29.0371 |
netEarningsPerShare: | 14.0127 |
currency: | USD |
year: | 2024 |
priceEarningsRatioCompany: | 28.0626 |
priceCashFlowRatio: | 28.7919 |
bookValuePerShare: | 68.0599 |
marketCap: | 101845605692.4800 |
earningsYield: | 3.5635 |
pegRatio: | 3.3701 |
cashFlowPerShare: | 13.6941 |
netAssetsPerShare: | 68.0599 |
priceBookValueRatio: | 5.7931 |
priceEarningsRatio: | 28.1373 |
netEarningsPerShare: | 14.0127 |
currency: | USD |